Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation

Scopus BioPharma Inc. (SCPS) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/16/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
09/02/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
08/15/2022 10-Q Quarterly Report for the period ended June 30, 2022
07/15/2022 8-K Quarterly results
05/27/2022 8-K Quarterly results
05/20/2022 8-K Quarterly results
05/19/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/13/2022 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
05/13/2022 8-K Quarterly results
05/04/2022 8-K Quarterly results
05/02/2022 10-K/A Annual Report for the period ended December 31, 2021 [amend]
04/29/2022 8-K Quarterly results
04/15/2022 10-K Annual Report for the period ended December 31, 2021
04/08/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
04/01/2022 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
03/24/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
03/23/2022 8-K Investor presentation
Docs: "Molecular Therapy, 2018 Patents US 9,688,982 US 10,758,624:"
03/04/2022 8-K Quarterly results
02/25/2022 8-K Changes in Registrant's Certifying Accountant  Interactive Data
02/18/2022 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits  Interactive Data
02/14/2022 SC 13G ARMISTICE CAPITAL, LLC reports a 10% stake in Scopus BioPharma Inc.
01/20/2022 8-K Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; T...
Docs: "AMENDMENT NO. 1 TO SECURITIES PURCHASE AGREEMENT",
"AMENDMENT NO. 1 TO REGISTRATION RIGHTS AGREEMENT"
01/20/2022 424B2 Form 424B2 - Prospectus [Rule 424(b)(2)]:
01/19/2022 EFFECT Form EFFECT - Notice of Effectiveness:
01/10/2022 8-K/A Submission of Matters to a Vote of Security Holders, Other Events  Interactive Data
01/05/2022 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
12/27/2021 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
12/22/2021 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
12/17/2021 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
12/17/2021 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
12/16/2021 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
12/07/2021 D Form D - Notice of Exempt Offering of Securities:
12/07/2021 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
12/07/2021 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy